Education
About Us
Working with TipRanks
Follow Us
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
Crinetics Pharmaceuticals (CRNX) Ownership Overview
1.93% Insiders
40.60% Mutual Funds
6.32% Other Institutional Investors
14.87% ETFs
36.28% Public Companies and Individual Investors
The ownership structure of Crinetics Pharmaceuticals (CRNX) stock is a mix of institutional, retail, and individual investors. Approximately 61.79% of the company’s stock is owned by Institutional Investors, 1.93% is owned by Insiders, and 36.28% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $31585569 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $240324581 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $269959181 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,248,367 | Institution | 8.69% | 353,195,075 | |
| 8,015,902 | Institution | 8.45% | 343,240,924 | |
| 6,400,025 | Institution | 6.74% | 274,049,071 | |
| 4,646,098 | Institution | 4.90% | 198,945,916 | |
| 4,199,087 | Institution | 4.43% | 179,804,905 | |
| 4,132,373 | Institution | 4.35% | 176,948,212 | |
| 2,428,352 | Institution | 2.56% | 103,982,033 | |
| 2,332,204 | Institution | 2.46% | 99,864,975 | |
| 2,056,360 | Institution | 2.17% | 88,053,335 | |
| 1,546,179 | Institution | 1.63% | 66,207,385 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,015,902 | Institution | 8.45% | 343,240,924 | |
| 4,132,373 | Institution | 4.35% | 176,948,212 | |
| 2,428,352 | Institution | 2.56% | 103,982,033 | |
| 2,332,204 | Institution | 2.46% | 99,864,975 | |
| 2,056,360 | Institution | 2.17% | 88,053,335 | |
| 1,546,179 | Institution | 1.63% | 66,207,385 | |
| 1,289,750 | Institution | 1.36% | 55,227,095 | |
| 1,122,210 | Institution | 1.18% | 48,053,032 | |
| 1,077,712 | Institution | 1.14% | 46,147,628 | |
| 1,053,066 | Institution | 1.11% | 45,092,286 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,958,595 | Institution | 3.12% | 123,225,482 | |
| 2,232,408 | Institution | 2.35% | 92,979,793 | |
| 2,195,352 | Institution | 2.31% | 94,004,973 | |
| 1,242,885 | Institution | 1.31% | 51,766,160 | |
| 1,013,827 | Institution | 1.07% | 42,225,895 | |
| 788,880 | Institution | 0.83% | 33,779,842 | |
| 547,535 | Institution | 0.58% | 23,445,449 | |
| 453,159 | Institution | 0.48% | 19,458,647 | |
| 430,688 | Institution | 0.45% | 17,938,155 | |
| 264,255 | Institution | 0.28% | 11,006,221 |
FAQ
Who Owns Crinetics Pharmaceuticals (CRNX)?
According to the latest TipRanks data, approximately 6.32% of the company's stock is held by institutional investors, 1.93% is held by insiders, and 36.28% is held by retail investors.
What percentage of Crinetics Pharmaceuticals (CRNX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.32% of Crinetics Pharmaceuticals (CRNX) stock is held by institutional investors.
What percentage of Crinetics Pharmaceuticals (CRNX) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.28% of Crinetics Pharmaceuticals (CRNX) stock is held by retail investors.
Who owns the most shares of Crinetics Pharmaceuticals (CRNX)?
Vanguard owns the most shares of Crinetics Pharmaceuticals (CRNX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.